Free Trial

10 Best Small Cap Stocks to Buy Now - 8 of 10

 
 

Aura Biosciences (NASDAQ:AURA)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$21.67 (147.9% Upside)

About Aura Biosciences

Aura Biosciences logoAura Biosciences, Inc, a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/16/2024Evercore ISIUpgradeStrong-Buy
9/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$21.00 ➝ $21.00
9/13/2024JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$19.00 ➝ $23.00
9/9/2024Lifesci CapitalUpgradeStrong-Buy
8/28/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$19.00 ➝ $19.00
7/25/2024HC WainwrightInitiated CoverageBuy$21.00
12/8/2023BTIG ResearchLower Price TargetBuy ➝ Buy$38.00 ➝ $21.00
11/10/2023JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$21.00 ➝ $19.00
7/27/2023ScotiabankInitiated CoverageSector Outperform$23.00
5/12/2023JMP SecuritiesLower Price Target$25.00 ➝ $24.00
 

Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available on replay.

Click here to watch it now.